SLXN - Silexion Therapeutics Corp
1.73
0.080 4.624%
Share volume: 21,929
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$1.65
0.08
0.05%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 08-29-2024 | 11-14-2024 | 03-18-2025 | 05-13-2025 | 11-12-2025 | |
| Assets | ||||||
| Total Assets | 2.525 M | 3.087 M | 2.863 M | 8.308 M | 11.614 M | |
| Current Assets | 2.315 M | 3.047 M | 2.250 M | 7.722 M | 11.055 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 66.000 K | 80.000 K | 62.000 K | 58.000 K | 47.000 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.697 M | 1.973 M | 1.187 M | 6.152 M | 9.243 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 40.000 K | 35.000 K | 30.000 K | 32.000 K | 26.000 K | |
| Other Assets | 170.000 K | 5.000 K | 583.000 K | 554.000 K | 533.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 2.525 M | 3.087 M | 2.863 M | 8.308 M | 11.614 M | |
| Total liabilities | 2.372 M | 7.666 M | 6.852 M | 5.722 M | 4.637 M | |
| Total current liabilities | 2.364 M | 3.583 M | 3.523 M | 2.395 M | 2.786 M | |
| Accounts Payable | 1.660 M | 2.657 M | 1.717 M | 1.615 M | 1.891 M | |
| Other liabilities | 8.000 K | 4.083 M | 3.329 M | 3.327 M | 1.851 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 8.000 K | 4.083 M | 3.329 M | 3.327 M | 1.851 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -18.257 M | -4.579 M | -3.989 M | 2.586 M | 6.977 M | |
| Common stock | 11.399 M | 37.004 M | 39.265 M | 47.575 M | 57.731 M | |
| Retained earnings | -29.656 M | -41.583 M | -43.254 M | -44.989 M | -50.754 M |